The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
Cannabis in Medicine 2020
DOI: 10.1007/978-3-030-45968-0_17
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoids in Gastrointestinal Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 92 publications
0
1
0
Order By: Relevance
“…Irritable bowel syndrome (IBS), also known as Crohn's disease (CD) and ulcerative colitis, is characterized by stomach pain, nausea, and changes in bowel habits (Hasenoehrl, Storr, & Schicho, 2017; Hor et al, 2020). Patients with inflammatory bowel disease (IBD) frequently use cannabis to relieve symptoms such as stomach discomfort, nausea, and diarrhoea, as well as to enhance their mood and, as a result, their quality of life.…”
Section: Ethnopharmacological Properties Of Cannabismentioning
confidence: 99%
“…Irritable bowel syndrome (IBS), also known as Crohn's disease (CD) and ulcerative colitis, is characterized by stomach pain, nausea, and changes in bowel habits (Hasenoehrl, Storr, & Schicho, 2017; Hor et al, 2020). Patients with inflammatory bowel disease (IBD) frequently use cannabis to relieve symptoms such as stomach discomfort, nausea, and diarrhoea, as well as to enhance their mood and, as a result, their quality of life.…”
Section: Ethnopharmacological Properties Of Cannabismentioning
confidence: 99%